Limited and External Funding Opportunities

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.
  • Want funding opportunities delivered straight to your inbox? Sign up for the OOR Weekly Update.

 

Have you been awarded a Limited Submission recognition?

Please let us know at LSO@vanderbilt.edu


Active Internal Calls Banner

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

Full internal call

  • Click on "View Full Internal Call" at end of each LSO description to access PDF with internal submission instructions 


2025 Pew Biomedical Scholars Program

Applications due March 1, 2024

VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

VUMC may nominate one candidate for the Pew Charitable Trusts' 2025 Pew Biomedical Scholars Award. The award supports Assistant Professors who demonstrate outstanding promise as contributors in science relevant to human health. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. Not more than 8 percent of the total award may be allocated for overhead costs.

Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles, but brings in concepts and theories from more diverse fields, are encouraged to apply. Ideas with the potential to produce an unusually high impact are encouraged. This program does not fund clinical trials research.

Full internal call


2025 Pew-Stewart Scholars for Cancer Research Program

Applications due March 1, 2024

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt-Ingram Cancer Center may nominate one candidate for the Pew Charitable Trusts' 2025 Pew-Stewart Scholars for Cancer Research Program. This program supports Assistant Professors of outstanding promise in science relevant to the advancement of a cure for cancer. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. Not more than 8 percent of the total award may be allocated for overhead costs.

Candidates should demonstrate outstanding promise as contributors in science relevant to the field of cancer. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied cancer research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply. This program does not fund clinical trials research.

Full internal call


NIH Collaborative Program Grant for Multidisciplinary Teams (RM1- Clinical Trial Optional)

Applications due March 7, 2024

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

VUMC may submit two proposals to the May 2024 cycle of the NIH Collaborative Program Grant for Multidisciplinary Teams (RM1).

This program is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of National Institute of General Medical Sciences (NIGMS) and are beyond the scope of an individual or a few investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields. While applications may request research program budgets of up to $1.5 million direct costs per year, it is anticipated that most awards will be between $700,000-$900,000 direct costs.

Full internal call


2024 V Foundation Adult Translational Cancer Research Awards

Applications due March 7, 2024

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU + VUMC, collaboratively) may choose one nominee for the V Foundation 2024 Adult Translational Cancer Research Grants Program. The grant provides $800,000 in four annual installments of $200,000. Indirect costs up to a maximum of 10% within the total award are permitted.

The V Foundation invites applications for adult cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

This RFA is specifically for adult cancer research that falls into preclinical/translational research as described above. This year, the foundation has special interest and funding for colorectal cancer and welcomes research projects in this area as well all other adult cancer research areas EXCEPT the following out-of-scope research areas: epidemiology, behavioral science, and health services research.

Full internal call


 

Active External Non-Limited Calls

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


HHMI Hanna H. Gray Fellows Program

Applications due February 28

Interested applicants are strongly encouraged to contact Sue Reeves, Foundation Relations (sue.reeves@vumc.org or 615-936-2964) before starting an application

Overview

The HHMI Hanna H. Gray Fellows program seeks to increase diversity in the professoriate by supporting early career researchers who show exceptional promise of becoming academic scientists, which includes the potential to build and contribute to an equitable and inclusive scientific culture. Through their successful careers, Hanna Gray Fellows will move science forward and will recruit, mentor, and inspire the next generation of scientists from all backgrounds.

Fellows receive funding up to $1.5M for their postdoctoral training and their early years as independent faculty. In addition to financial support, they benefit from professional development, mentorship, a cohort of peers, and inclusion in HHMI’s broader scientific community. 

External call

The Mark Foundation for Cancer Research Endeavor Award

LOIs due March 12

Interested applicants are strongly encouraged to contact Sue Reeves, Foundation Relations (sue.reeves@vumc.org or 615-936-2964) before starting an application

Overview

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants of $3M over 3 years are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

External call

Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians

Applications due May 13

Overview

Winn CDA is one of the program initiatives of the Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards)a $122 million initiative funded by Bristol Myers Squibb Foundation (BMSF), Gilead Sciences, and Amgen. This national program is designed to increase diversity in clinical trials and transform the clinical research landscape. 

Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians who are underrepresented in medicine (URiM) or who have a demonstrated commitment to increasing diversity in clinical research. The program prepares participants to become independent clinical trial investigators engaged in advancing health equity through their research and mentoring. The goal of Winn CDA is to transform the clinical research landscape by building and strengthening partnerships between clinical investigators and the communities where their patients reside, with a goal of ultimately engaging a patient population that mirrors the epidemiology of the disease studied.

Winn CDA provides $120K/year salary support for 2 years; funding is to protect 40% of the Scholars’ work time for program participation and research. 

External call


HHMI Freeman Hrabowski Scholars Program

Applications due May 15

Overview

The HHMI Freeman Hrabowski Scholars program supports outstanding basic researchers, including physician-scientists, who have strong potential to become leaders in their fields and to advance diversity, equity, and inclusion through their mentoring efforts and understanding of systemic exclusion and marginalization in science of trainees from different backgrounds. Scholars will prioritize scientific excellence in their own research while creating an inclusive lab climate that serves as a model within their own institutions and beyond.

Scholars are appointed to a five-year term, renewable for a second five-year term after a successful progress evaluation. Each Scholar receives up to $8.6M over the ten-year period, including full salary, benefits, a research budget, and scientific equipment. They also participate in professional development to advance their leadership and mentoring skills.

External call